Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

The Central and Eastern Europe Fund, Inc. (CEE)

NYSE - NYSE Delayed Price. Currency in USD
8.02+0.16 (+2.04%)
At close: 04:00PM EST
8.05 +0.03 (+0.37%)
After hours: 06:03PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Williams %R

Williams %R

Previous Close7.86
Open7.83
Bid8.05 x 1200
Ask8.09 x 900
Day's Range7.83 - 8.02
52 Week Range6.10 - 27.29
Volume32,366
Avg. Volume48,030
Market Cap49.885M
Beta (5Y Monthly)1.29
PE Ratio (TTM)0.58
EPS (TTM)13.91
Earnings DateN/A
Forward Dividend & Yield0.95 (12.52%)
Ex-Dividend DateDec 29, 2021
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CEE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • The Central and Eastern Europe
    Analyst Report: Dr. Reddy's Laboratories LimitedHeadquartered in India, Dr. Reddy’s Laboratories develops and manufactures generic pharmaceutical products sold across the world. The company specializes in low-cost, easy-to-produce small-molecule generic drugs and active pharmaceutical ingredients. Its drug portfolio in recent years has included biosimilar drug launches in select emerging markets and has shifted toward injectables and more complex generic products. Geographically, the company’s sales are well dispersed across North America, India, and other emerging markets.
    Rating
    Fair Value
    Economic Moat
    last monthMorningstar
View more
Advertisement
Advertisement